Insider selling
Traded Nov 17 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 20 min ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider selling
Traded Nov 17 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade
A Magnite director sold $501K of Magnite shares. The filing does not indicate a pre-arranged trading plan.
Lately at Magnite: the stock rose 21% in one session on Nov 5 around a company release; it reported its results on Nov 4; insiders made no purchase ($10K+) and 5 large sales ($250K+, not pre-arranged) in 90 days.
Traded Nov 17 – Nov 18, 2026 · largest single transaction ~$296KNot reported under a pre-arranged trading plan
Lately at Expensify: it reported its results on Nov 5; the stock is down 44% in 30 days; insiders made no purchase ($10K+) and 6 large sales ($250K+, not pre-arranged) in 90 days.
Nov 17, 2026~$296K · 178K sh @ $1.66
DetailsOfficial recordNov 18, 2026~$259K · 160K sh @ $1.62
DetailsOfficial recordInsider selling
Traded Nov 19 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −11.6% · S&P 500 −3.6% · to Nov 20
A Flotek Industries director sold $382K of Flotek Industries shares. The filing does not indicate a pre-arranged trading plan.
Lately at Flotek Industries Inc: it reported its results on Nov 3; the stock is down 14% in 30 days; insiders made no purchase ($10K+) and 3 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 17 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade +0.1% · S&P 500 −5.8% · to Nov 20
FTI Consulting's Chief Strategy/Transf. Officer sold $518K of FTI Consulting shares. The filing does not indicate a pre-arranged trading plan.
Lately at FTI Consulting: the stock rose 14% in one session on Oct 29 around a company release; it announced job cuts, closures or a restructuring on Oct 30; the stock is up 38% in 30 days.
Insider selling
Traded Oct 1 · filed 49 days laterNot reported under a pre-arranged trading plan
Since the trade −73.2% · S&P 500 −9.7% · to Nov 20
A major shareholder of Bioaffinity Technologies sold $268K of Bioaffinity Technologies shares. The filing does not indicate a pre-arranged trading plan.
Lately at Bioaffinity Technologies: it changed its bylaws, charter or fiscal year on Nov 20; the stock is down 54% in 30 days; insiders made 10 purchases ($10K+) and 1 large sale ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 15 · filed 4 days laterNot reported under a pre-arranged trading plan
Since the trade −8.1% · S&P 500 −8.6% · to Nov 20
An Amdocs director sold $314K of Amdocs shares. The filing does not indicate a pre-arranged trading plan.
Lately at Amdocs: the stock fell 30% in one session on Nov 4 with press coverage; the stock is down 33% in 30 days; insiders made 7 purchases ($10K+) and 2 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 18 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −5.1% · S&P 500 −5.5% · to Nov 20
A Crane director sold $319K of Crane shares. The filing does not indicate a pre-arranged trading plan.
Lately at Crane: it reported its results on Oct 27.
Insider selling
Traded Nov 17 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −5.5% · S&P 500 −5.8% · to Nov 20
A Booz Allen Hamilton director sold $306K of Booz Allen Hamilton shares. The filing does not indicate a pre-arranged trading plan.
Lately at Booz Allen Hamilton: it reported its results on Oct 23; the stock is up 8% in 30 days.
Insider selling
Traded Nov 17 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −11.4% · S&P 500 −5.8% · to Nov 20
First Watch Restaurant's Chief People Officer sold $396K of First Watch Restaurant shares. The filing does not indicate a pre-arranged trading plan.
Lately at First Watch Restaurant Group: it reported its results on Nov 3; the stock is 38% below its 12-month high; insiders made no purchase ($10K+) and 3 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 18 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −3.2% · S&P 500 −5.5% · to Nov 20
Matson's Senior Vice President sold $321K of Matson shares. The filing does not indicate a pre-arranged trading plan.
Lately at Matson, Inc.: it reported its results on Nov 4; the stock is down 15% in 30 days.
Insider selling
Traded Nov 17 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −4.7% · S&P 500 −5.8% · to Nov 20
Leidos's Sector President sold $299K of Leidos shares. The filing does not indicate a pre-arranged trading plan.
Lately at Leidos: it reported its results on Nov 3; the stock is down 5% in 30 days.
Insider selling
Traded Nov 18 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −1.7% · S&P 500 −5.5% · to Nov 20
BioMarin Pharmaceutical's Chief R&D Officer sold $303K of BioMarin Pharmaceutical shares. The filing does not indicate a pre-arranged trading plan.
Lately at BioMarin Pharmaceutical: it reported its results on Nov 2; the stock is up 9% in 30 days; insiders made no purchase ($10K+) and 2 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 17 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade 0.0% · S&P 500 −5.8% · to Nov 20
O'Reilly Automotive's SVP OF INTERNATIONAL sold $274K of O'Reilly Automotive shares. The filing does not indicate a pre-arranged trading plan.
Lately at O'Reilly Automotive: it reported its results on Oct 28; insiders made no purchase ($10K+) and 5 large sales ($250K+, not pre-arranged) in 90 days; members of Congress disclosed no purchase and 2 sales in 90 days.
Insider buying
Open-market purchases, traded Nov 16, 2026. Each amount is that person's own.
Two of these filings report the same value. Joint filers can report the same shares, so the amounts are not added up.
Lately at Windward Bio Group: insiders made 4 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
1 day before an 8-KTraded Nov 18 · filed the same day
Since the trade −3.1% · S&P 500 −5.5% · to Nov 20
Bought 45% below the 52-week high, RSI 42, 27% under its 200-day average, 21 points behind the S&P 500 over 3 months
A LKQ director paid $496K out of pocket for LKQ shares. 3 other people at LKQ bought some too, in the same month. It was the first purchase in 15 months.
Lately at LKQ Corporation: the stock fell 22% in one session on Oct 23 around a company release; it changed a top executive or board member on Nov 19; the stock is down 13% in 30 days.
Insider buying
First insider buy since Sep 2025Traded Nov 18 · filed the same day
Since the trade −0.7% · S&P 500 −5.5% · to Nov 20
Bought 6% below the 52-week high, RSI 63, 19% above its 200-day average
The CEO of Cg Oncology paid $2.37M out of pocket for Cg Oncology shares. 1 other person at Cg Oncology bought some too, in the same month. It was the first purchase in over a year.
Lately at Cg Oncology: the stock rose 14% in one session on Nov 16 around a company release; it reported its results on Nov 6; the stock is up 28% in 30 days.
Insider buying
3 insiders in a week, 2nd time since 2009Traded Nov 16 · filed 2 days later
Since the trade −7.8% · S&P 500 −6.8% · to Nov 20
Bought within 4% of the 52-week low, RSI 38, 27% under its 200-day average, 24 points behind the S&P 500 over 3 months
A Starwood Property Trust director paid $2.02M out of pocket for Starwood Property Trust shares. 2 other people at Starwood Property Trust bought some too, in the same month. Shares held went up 1464% with this purchase.
Lately at Starwood Property Trust: it reported its results on Nov 6; the stock is down 11% in 30 days; insiders made 5 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Their first buy on recordTraded Nov 17 · filed 1 day later
Since the trade −4.9% · S&P 500 −5.8% · to Nov 20
Bought at the 52-week low, RSI 31, 23% under its 200-day average, 21 points behind the S&P 500 over 3 months
A Boeing director paid $500K out of pocket for Boeing shares. 2 other people at Boeing bought some too, in the same month. It was the first purchase in over a year.
Lately at Boeing: the stock fell 11% in one session on Oct 27 around a company release; it reported its results on Oct 27; the stock is down 19% in 30 days.